Sound Income Strategies’s Trillium Therapeutics Inc. TRIL Stock Holding History

Sound Income Strategies’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000	Closed	-$18K	–	913
2021 Q3	$18K	Hold	1,000	–	–	﹤0.01%	367
2021 Q2	$10K	Buy	+1,000	New	+$9.41K	﹤0.01%	492

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Sound Income Strategies's TRIL Position: Q4 2021 in Review

Sound Income Strategies sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 1,000 shares — an estimated $18K sold.

Sound Income Strategies first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $18K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Sound Income Strategies reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Sound Income Strategies sold 1,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $18K.
Sound Income Strategies first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
Sound Income Strategies's Trillium Therapeutics Inc. position peaked at $18K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Sound Income Strategies's 13F filing for Q4 2021, filed 13 Jan 2022.